Partner Josephine Young spoke at a panel on June 28, 2023 at the American Conference Institute’s 14th Summit on Biosimilars & Innovator Biologics, titled “Biologics Ethics Module: Understanding the Duties of Disclosure and Reasonable Inquiry.”  The panel discussed the duties of disclosure and reasonable inquiry, strategies for timing USPTO and FDA submissions, acceptable access to samples of the reference product needed by the biosimilar, as well as discussing when false or misleading communications about biosimilars amount to anticompetitive practices.